Cancer Immunotherapy, Part 1: Current Strategies and Agents

Food and Drug Administration’s 2014 breakthrough approvals of new agents for chronic lymphocytic ... Thanks to the Internet, today’s cancer patient is better informed than ever; however, less than 10 percent of eligible patients enroll in clinical trials. Few patients want to be placed under the demands of an early ................
................